Peramivir
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 534 publications
Influenza Virus Neuraminidase Glycoprotein, Its Inhibitors, and Their Resistance.
Journal: Advances in experimental medicine and biology
Published: March 31, 2026
Rapid progression from croup to complete lung collapse: a case report of central airway obstruction by mucopurulent cast in influenza A (H3N2) and Pseudomonas aeruginosa coinfection in a toddler.
Journal: Frontiers in pediatrics
Published: February 02, 2026
Association of severe abnormal behavior of influenza patients and administered anti-influenza virus drugs: 2006-2022.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 21, 2026
In vitro efficacy of anti-influenza active compounds against clinical isolates with high growth capability.
Journal: Archives of virology
Published: January 10, 2026
Influenza Antiviral Prescriptions in the US Inpatient and Outpatient Settings During the 2015-2022 Influenza Seasons.
Journal: Influenza and other respiratory viruses
Published: December 18, 2025
A mouse model of human-derived H10N3 influenza enables preclinical evaluation of antiviral efficacy.
A mouse model of human-derived H10N3 influenza enables preclinical evaluation of antiviral efficacy.
Journal: Antiviral research
Published: December 09, 2025
Comprehensive evaluation of therapeutic effectiveness and safety profiles of baloxavir marboxil for managing influenza virus infection in pediatric populations: a systematic review with pooled meta-analytic data.
Journal: Frontiers in pediatrics
Published: October 27, 2025
Comparison table: Antiviral drugs for seasonal influenza for 2025-2026.
Journal: The Medical letter on drugs and therapeutics
Published: October 21, 2025
Antiviral drugs for seasonal influenza for 2025-2026.
Journal: The Medical letter on drugs and therapeutics
Published: October 21, 2025
Influenza vaccines for 2025-2026.
Journal: The Medical letter on drugs and therapeutics
Published: September 22, 2025
Integrated Phenotypic-Genotypic Surveillance of Neuraminidase Inhibitor Susceptibility in Influenza A(H1N1), A(H3N2), and B/Victoria Viruses in Saudi Arabia, 2024-2025.
Journal: Journal of medical virology
Published: September 19, 2025
Last Updated: 06/30/2026